
Del Monte Corporation (NYSE:DMC) reported second-quarter net sales of $1,219.1 million and an earnings per diluted share of $0.44.
The revenue increase was driven by the prepared foods segment following the March 2026 acquisition of Del Monte Foods, offsetting lower banana sales in North America and Asia.
The company recorded a gross profit of $121.3 million, yielding a gross margin of 9.9% as higher production, procurement, and ocean freight costs impacted operations.
Operating income declined to $33.5 million primarily due to higher asset impairment and acquisition-related expenses, while adjusted operating income reached $48.7 million.
Following the announcement, Del Monte's share price was up at $28.73.
The company also reported a net income of $21.2 million, or $34.2 million on an adjusted basis, for the quarter ended June 26, 2026.
Unfavorable foreign currency impacts related to the Costa Rican colon and the late 2025 divestiture of the Mann Packing business further influenced the quarterly financial results.
Del Monte Corporation Chairman and CEO Mohammad Abu-Ghazaleh joined Bloomberg Open Interest to explain why the iconic food brand reunited after nearly four decades and discusses easing supply chain pressures. He also reveals some surprising pharmaceutical research using pineapple-derived compounds